10 results on '"Jones, Peter J.H."'
Search Results
2. Nutrient essentiality revisited.
- Author
-
Jew, Stephanie, Antoine, Jean-Michel, Bourlioux, Pierre, Milner, John, Tapsell, Linda C., Yang, Yuexin, and Jones, Peter J.H.
- Abstract
With increased understanding of the complex roles nutrients play within metabolic pathways, the purpose of this contribution is to explore the rationale for expanding the definitions and criteria for nutrient essentiality. A further objective was to develop three case study scenarios to probe issues surrounding the definition of essentiality using dietary fibre, plant sterols and polyphenols. Current definitions and criteria for “essentiality” were reviewed through an environmental scan of the scientific literature. Additionally, international regulatory bodies were asked whether the terms “nutrient” and/or “essential nutrient” are regulated in their respective jurisdictions. Regulatory bodies including the EFSA, the US FDA, HC and FSANZ were found not to currently possess regulated definitions for the term “essential nutrient”. Case studies examining fibre, plant sterols and polyphenols served as a means of presenting evidence for expanding the list of functional food constituents regarded as meeting criteria for essentiality. For each example, certain instances applied where these case study bioactives met criteria of essentiality. Thus, in order to reflect advances in current science, a series of non-classical compounds known to have bioactivity should be considered for their potential essentiality under certain situations. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
3. Water dispersible plant sterol formulation shows improved effect on lipid profile compared to plant sterol esters.
- Author
-
Amir Shaghaghi, Mandana, Harding, Scott V., and Jones, Peter J.H.
- Abstract
Highlights: [•] Plant sterols (PS) have been reported to reduce LDL-cholesterol levels by 7–15%. [•] Reduced bioavailability in some formulation of PS account in part for the variable results. [•] It may be preferred to examine the efficacy of every new formulation of PS. [•] We examined the efficacy and safety of a new water dispersible PS versus PS-esters. [•] The formulation of water dispersible PS showed overall better lipid level management. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
4. Modulation of apolipoprotein A1 and B, adiponectin, ghrelin, and growth hormone concentrations by plant sterols and exercise in previously sedentary humans.
- Author
-
Collins, Melissa, Varady, Krista A., and Jones, Peter J.H.
- Subjects
APOLIPOPROTEINS ,CHOLESTEROL ,PHARMACOLOGY ,STEROLS ,CORONARY disease - Abstract
Copyright of Canadian Journal of Physiology & Pharmacology is the property of Canadian Science Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2007
- Full Text
- View/download PDF
5. Dietary agents that target gastrointestinal and hepatic handling of bile acids and cholesterol.
- Author
-
Jones, Peter J.H.
- Subjects
DIET ,GASTROINTESTINAL system ,BILE acids ,CHOLESTEROL - Abstract
Abstract: Several food components have been demonstrated to exhibit cholesterol-lowering properties by interfering with cholesterol absorption and bile-acid trafficking. Such components include stearic acid, plant sterols, soluble fiber, and soy protein. Among saturated fatty acids, stearic acid is unique in its ability to reduce circulatory low-density lipoprotein cholesterol levels. This action is accompanied by an observed suppression in cholesterol absorption, an effect seen repeatedly in animal and human studies. Proposed mechanisms include micellar exclusion of cholesterol by this high melting point fatty acid, as well as the ability of stearate to alter the biliary ratios of primary to secondary bile acids, leading to a reduction in hydrophobicity index and lower overall solubility of sterols in micelles. Another dietary ingredient that interferes with absorption of sterols is soy protein, in which studies in animals and humans have identified that compared to casein, consumption of soy protein reduces intestinal absorption of cholesterol while enhancing fecal cholesterol excretion. Considerable investigation using free amino acid mixtures mirroring the composition of soy versus animal proteins has determined that co-existing agents other than soy’s amino acid pattern are likely responsible for the inhibitory action of soy protein on sterol uptake. Recently, it has been shown that hydrolysates of soy protein appear to be effective in reducing sterol absorption; these are now being targeted as the possible factor responsible for the overall effect of this dietary ingredient. Plant sterols appear to impact absorption of sterols through several mechanisms, including competition with cholesterol for incorporation into micelles, co-crystallization with cholesterol to form insoluble crystals, interaction with digestive enzymes, and inhibition of cholesterol transporter proteins. Clinical trials attest to plant sterols lowering cholesterol absorption by 20% to 40%, an extent beyond which cholesterogenesis can compensate to restore normal circulatory cholesterol levels. As such, 2 g/day of plant sterols effectively lowers low-density lipoprotein cholesterol by 8% to 12%. Dietary soluble fiber represents another means of reducing intestinal cholesterol uptake, in part through enhanced bile-acid clearance through the gut. Pectin, β-glucans, fructans, and gums have been identified as agents that can work through the production of a viscous matrix that hinders movement of cholesterol and bile acids into micelles as well as the subsequent uptake of micelles into the enterocyte. Additional work on design of novel fibers that impede sterol absorption is warranted. In summary, a number of novel dietary factors exist that contribute to heart disease risk reduction via mechanisms that involve cholesterol absorption inhibition and/or biliary pathway perturbation. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
6. Non-cholesterol sterols and cholesterol metabolism in sitosterolemia.
- Author
-
Othman, Rgia A., Myrie, Semone B., and Jones, Peter J.H.
- Subjects
- *
CHOLESTEROL metabolism inhibitors , *STEROLS analysis , *CHOLESTYRAMINE , *XANTHOMA , *ENTEROHEPATIC circulation , *ATHEROSCLEROSIS - Abstract
Abstract: Sitosterolemia (STSL) is a rare autosomal recessive disease, manifested by extremely elevated plant sterols (PS) in plasma and tissue, leading to xanthoma and premature atherosclerotic disease. Therapeutic approaches include limiting PS intake, interrupting enterohepatic circulation of bile acid using bile acid binding resins such as cholestyramine, and/or ileal bypass, and inhibiting intestinal sterol absorption by ezetimibe (EZE). The objective of this review is to evaluate sterol metabolism in STSL and the impact of the currently available treatments on sterol trafficking in this disease. The role of PS in initiation of xanthomas and premature atherosclerosis is also discussed. Blocking sterols absorption with EZE has revolutionized STSL patient treatment as it reduces circulating levels of non-cholesterol sterols in STSL. However, none of the available treatments including EZE have normalized plasma PS concentrations. Future studies are needed to: (i) explore where cholesterol and non-cholesterol sterols accumulate, (ii) assess to what extent these sterols in tissues can be mobilized after blocking their absorption, and (iii) define the factors governing sterol flux. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
7. Cholesterol-Lowering Efficacy of Plant Sterols/Stanols Provided in Capsule and Tablet Formats: Results of a Systematic Review and Meta-Analysis.
- Author
-
Amir Shaghaghi, Mandana, Abumweis, Suhad S., and Jones, Peter J.H.
- Subjects
- *
PHARMACEUTICAL encapsulation , *DRUG tablets , *CLINICAL trials , *COMPARATIVE studies , *CONFIDENCE intervals , *DIET therapy , *LOW density lipoproteins , *META-analysis , *STEROLS , *SYSTEMATIC reviews , *ODDS ratio , *THERAPEUTICS - Abstract
Abstract: Plant sterols/stanols-enriched foods possess well-documented low-density lipoprotein (LDL)-cholesterol−lowering effect. However, the relative efficacy of plant sterols/stanols as supplements (tablets/capsules) compared with other dietary forms still needs to be determined. Our aim was to precisely identify and quantify the LDL-cholesterol−lowering effect of plant sterols/stanols as supplements in contrast to food-based approaches. Eight eligible clinical trials published from January 1992 to April 2013 were identified from five databases. A random effect model was used to calculate weighted mean effect sizes for net differences in LDL-cholesterol concentrations. Among the included trials with the duration between 4 and 6 weeks, plant sterol/stanol dose ranged from 1.0 to 3.0 g/day administrated mainly with the main meals (2 or 3 times/day). Intake of plant sterol/stanol supplements decreased LDL-cholesterol concentrations by 12 mg/dL (0.31 mmol/L) (95% CI −0.39 to −0.23; P<0.000) compared with placebo. The test of heterogeneity was not significant (χ2 , P=0.50, I 2=0%). Further analysis showed no significant difference between the LDL-cholesterol−lowering action of plant sterols/stanols supplements (−12 mg/dL [−0.31 mmol/L]; 95% CI −0.39 to −0.24; P<0.0001) vs foods enriched with plant sterols/stanols (−12 mg/dL [−0.31 mmol/L]; 95% CI −0.35 to −0.27; P<0.0001). Plant sterol/stanol supplements as part of a healthy diet represent an effective means of delivering LDL-cholesterol−lowering similar to plant sterols/stanols delivered in various food formats. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
8. Plant sterols combined with exercise for the treatment of hypercholesterolemia: overview of independent and synergistic mechanisms of action
- Author
-
Marinangeli, Christopher P.F., Varady, Krista A., and Jones, Peter J.H.
- Subjects
- *
LIPIDS , *STEROIDS , *CHOLESTEROL , *LIPOPROTEIN lipase , *THERAPEUTICS - Abstract
Abstract: At present, dyslipidemia is most commonly treated with lipid-altering pharmacological therapies. However, safety concerns regarding the use of these agents have prompted the need for safe and efficacious nonpharmacological lipid-altering interventions. One such natural therapy is the combination of plant sterols and endurance training. This combination lifestyle intervention has been shown to decrease total cholesterol, low-density lipoprotein (LDL) cholesterol and triglyceride concentrations while increasing high-density lipoprotein (HDL) cholesterol concentrations. However, the mechanisms that underlie these positive lipid alterations have yet to be clarified. Thus, the purpose of this review is to evaluate individual effects of plant sterols and exercise training on lipid levels while attempting to elucidate the possible independent and synergistic mechanisms of action responsible for these modulations. Results reveal that plant sterols decrease both total and LDL cholesterol levels by reducing exogenous cholesterol absorption by way of cholesterol displacement in the intestinal lumen. Additionally, the intestinal membrane transport proteins, ABCG5, ABCG8, as well as NPC1L1, have also been implicated in plant sterol-mediated cholesterol lowering. Conversely, exercise decreases triglyceride levels by reducing hepatic very low-density lipoprotein secretion and increasing skeletal lipoprotein lipase activity. In addition, endurance training was shown to increase HDL cholesterol levels by way of HDL subfraction alterations, in conjunction with changing reverse cholesterol transport enzyme activities. Moreover, plant sterols and exercise may work synergistically to alter lipid levels by modulating lipoprotein transport, composition, release and metabolism. In sum, the present review lends further insight as to the metabolic benefits of adopting a healthy lifestyle, including plant sterols and endurance training, in the treatment of dyslipidemia. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
9. Effects of different phytosterol analogs on colonic mucosal cell proliferation in hamsters
- Author
-
Jia, Xiaoming, Ebine, Naoyuki, Wang, Yanwen, Awad, Atif B., and Jones, Peter J.H.
- Subjects
- *
CELL proliferation , *STEROLS , *DIET , *ANIMAL feeding behavior , *COLON (Anatomy) , *HAMSTERS as laboratory animals - Abstract
Abstract: Objective: The aim of this study was to investigate the effects of different phytosterols and their analogs on colonic mucosal cell proliferation in hamsters. Method: Hamsters (n=70) were randomly assigned to seven groups after a 2-week acclimation and fed the experimental diet for 5 weeks. Diets included (i) the semipurified diet with no cholesterol (Con), (ii) the Con diet plus 0.25% cholesterol (Ch-con), or the Ch-con diet with (iii) 1% phytosterols (Ste), (iv) 1% phytostanols (Sta), (v) 1.76% sterol esters (esterified to fish oil, SteF), (vi) 0.71% stanol esters (esterified to ascorbic acid [disodium ascorbyl phytostanol phosphate, FM-VP4], 0.7% StaA) and (vii) 1.43% stanol esters (1.4% StaA), respectively. After 5 weeks on experimental diet, hamsters were sacrificed, and colons were collected. Colonic mucosal cell proliferation was measured by immunohistochemistry using monoclonal antibodies against antigen Ki-67. Results: Colonic mucosal cell proliferation was 21.4% (P<.01) lower in the 0.7%, but not 1.4%, StaA relative to the Ch-con group. In addition, a lower (−13.9%) cell proliferation was observed in the SteF group in comparison to the Ch-con group; however, this difference achieved only a borderline level of statistical significance (P=.069). No differences were observed between Con and Ch-con, as well as among Ste, Sta, 1.4% StaA and Ch-con treatments. Conclusion: Plant stanols esterified to ascorbic acid may possess anticarcinogenic properties in the colon by suppressing colonic mucosa cell proliferation; however, this effect was not observed with free plant sterols or stanols. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
10. The Garden of Eden—plant based diets, the genetic drive to conserve cholesterol and its implications for heart disease in the 21st century
- Author
-
Jenkins, David J.A., Kendall, Cyril W.C., Marchie, Augustine, Jenkins, Alexandra L., Connelly, Philip W., Jones, Peter J.H., and Vuksan, Vladimir
- Subjects
- *
FOOD consumption , *HUMAN evolution , *GENETICS , *PHYTOCHEMICALS - Abstract
It is likely that plant food consumption throughout much of human evolution shaped the dietary requirements of contemporary humans. Diets would have been high in dietary fiber, vegetable protein, plant sterols and associated phytochemicals, and low in saturated and trans-fatty acids and other substrates for cholesterol biosynthesis. To meet the body''s needs for cholesterol, we believe genetic differences and polymorphisms were conserved by evolution, which tended to raise serum cholesterol levels. As a result modern man, with a radically different diet and lifestyle, especially in middle age, is now recommended to take medications to lower cholesterol and reduce the risk of cardiovascular disease. Experimental introduction of high intakes of viscous fibers, vegetable proteins and plant sterols in the form of a possible Myocene diet of leafy vegetables, fruit and nuts, lowered serum LDL-cholesterol in healthy volunteers by over 30%, equivalent to first generation statins, the standard cholesterol-lowering medications. Furthermore, supplementation of a modern therapeutic diet in hyperlipidemic subjects with the same components taken as oat, barley and psyllium for viscous fibers, soy and almonds for vegetable proteins and plant sterol-enriched margarine produced similar reductions in LDL-cholesterol as the Myocene-like diet and reduced the majority of subjects’ blood lipids concentrations into the normal range. We conclude that reintroduction of plant food components, which would have been present in large quantities in the plant based diets eaten throughout most of human evolution into modern diets can correct the lipid abnormalities associated with contemporary eating patterns and reduce the need for pharmacological interventions. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.